WI
BBP icon

WBI Investments’s Virtus Biotech ETF BBP Stock Holding History

WBI Investments’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
+15,894
New +$1.31M 0.36% 60

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

WBI Investments's BBP Position: Q1 2026 in Review

WBI Investments opened a new position in Virtus Biotech ETF (BBP) in Q1 2026: 15,894 shares worth $1.32M. The stake represents 0.36% of the portfolio and ranks #60 among its holdings.

26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • WBI Investments held 15,894 shares of Virtus Biotech ETF worth $1.32M as of Q1 2026.
  • Virtus Biotech ETF was a new WBI Investments position in Q1 2026.
  • Virtus Biotech ETF made up 0.36% of WBI Investments's portfolio in Q1 2026, its #60 holding.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.